[ET Net News Agency, 8 March 2024] IMMUNEONCO-B (01541) rose 30.3% to HK$27.95,
breaking above the 100-D SMA of HK$26.133.
It hits an intra-day high of HK$27.95, and an intra-day low of HK$22.1. The total shares
traded was 126,000, with a value of HK$3.12m. The active buy/sell ratio is 64:36, with net
buying turnover of HK$823,810. CHINA INV INFO accounts for greatest net responsive buying
turnover of HK$214,030, with volume weighted average price of HK$24.857. CHINA INNOVATION
MARKET SER accounts for greatest net responsive selling turnover of HK$186,750, with
volume weighted average price of HK$24.692. The stock has risen a combined 94.1% over the
past 2 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 27.950 % Chg +30.30%
High 27.950 Low 22.100
Shares Tr 126,000 Turnover 3.12m
10-D SMA 20.567 %H.V 188.944
20-D SMA 20.057 VWAP 24.725
50-D SMA 23.526 RSI14 62.279
-----------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 64:36, with net buying
turnover of HK$823,810, rising a combined 94.1% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 27.95 +30.30
GENSCRIPT BIO (01548) 14.70 +2.23
INNOVENT BIO (01801) 39.45 +2.47
EVEREST MED-B (01952) 26.10 +1.56
LAEKNA-B (02105) 7.99 +12.38
WUXI XDC (02268) 21.70 +3.83
WUXI BIO (02269) 17.54 +2.69
TIGERMED (03347) 25.45 +3.46
BEIGENE (06160) 97.65 +2.04
AKESO (09926) 45.15 +1.57
---------------------------------------------
(ed)